Analysis

Deep dives comparing drugs, costs, pipelines, and clinical data. Evergreen with opinions.

17 articles.

Start here

Choose the question you want to answer first.

Cost

Compare treatment costs

Monthly prices, upfront payments and plan terms.

Pills

Explore GLP-1 pills

Oral options, formulations and the differences to check.

Medications

Semaglutide vs tirzepatide

Understand the medications before comparing programs.

Coverage

Understand Medicare coverage

Coverage paths, program conditions and next steps.

Looking for your state? Browse state coverage guides
Two smooth grey river stones of different sizes resting side by side on a folded linen cloth in soft morning light
AnalysisNews & Pipeline

Saxenda Is Being Discontinued in January 2027: What Is Actually Ending, and What Switching Really Costs You

Yes. Novo Nordisk is discontinuing Saxenda, with last shipments to wholesalers in late January 2027, and says the decision is not about safety or quality. Victoza stays on the market, and so do the Hikma, Meitheal and Teva-distributed generic liraglutide lines. No FDA label gives a dose conversion from Saxenda to Wegovy or Zepbound, so plan the switch with your prescriber.

August 27, 2026

10 min read

Editorial still-life illustrating retatrutide, a Phase 3 triple-agonist weight loss drug
AnalysisNews & Pipeline

Retatrutide TRIUMPH-1 Results (May 2026): 30.3% Weight Loss, Phase 3 Primary Trial

Updated August 5, 2026: Added Lilly's ClinicalTrials.gov expanded-access record (NCT07629401), registered June 5, 2026, which lists no eligibility criteria. Biologic classification lawsuit context (Lilly v. FDA, Case 1:24-cv-01503). Obesity (TRIUMPH-1): 28.3% weight loss at 80 weeks, 30.3% at 104 weeks, 65.3% achieved BMI <30. T2D (TRANSCEND-T2D-1): A1C −2.0%, weight −16.8%. NDA expected Q4 2026. Court ruling: FDA's bright-line classification of retatrutide as a drug (not biologic) vacated. Outcome determines whether compounding can legally exist post-approval.

August 5, 2026

11 min read

A single glass of water sitting still on a flat weathered oak table, morning light through sheer curtains, nothing in motion
AnalysisGuides

Ozempic Plateau: Why You Stopped Losing Weight

A weight plateau on semaglutide or tirzepatide has four separate causes, and they do not share an answer. Here is how to tell which one you are looking at, using what the STEP and SURMOUNT trials actually measured.

August 2, 2026

9 min read

Editorial lifestyle photograph illustrating semaglutide before-and-after weight loss timeline
AnalysisGuides

Semaglutide Before and After: Weight Loss Results by Month

Clinical trials show 14.9-20.7% body weight loss with semaglutide depending on dose. Standard Wegovy (2.4mg): 14.9-17% over 68 weeks. Wegovy HD (7.2mg, FDA-approved March 2026): 20.7% over 72 weeks. Month-by-month breakdown from the STEP trials.

July 17, 2026

12 min read

Editorial still-life illustrating Foundayo and Wegovy pill comparison for weight loss
AnalysisComparisons

Foundayo vs Wegovy Pill: Which Is Cheaper and What Differs (2026)

Foundayo and the Wegovy pill both cost $149 a month at the starting dose. After that, the Wegovy pill costs $199 at 4 mg and $299 at 9 or 25 mg, while Foundayo stays at $149 at 2.5 mg and $199 at 5.5 mg through December 31, 2026. We checked both makers' prices on October 16, 2026.

July 16, 2026

20 min read

Editorial still-life illustrating a head-to-head semaglutide and tirzepatide comparison
AnalysisComparisons

Semaglutide vs Tirzepatide: Weight Loss, Side Effects and Cost

Tirzepatide caused more weight loss than semaglutide in the SURMOUNT-5 trial: 20.2% against 13.7% over 72 weeks, in adults with obesity without diabetes. Both cause similar stomach side effects. Without insurance, Zepbound starts at $299 a month from LillyDirect, and the Wegovy pen costs $199 for the first two low-dose fills, then $349.

July 15, 2026

11 min read

Unbranded vial on a folded blank statement with green glass behind it, a conceptual illustration of treatment costs.
AnalysisCost & Insurance

GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)

Without insurance, brand GLP-1s cost $149 to $499 a month direct from the makers: Foundayo and the Wegovy pill from $149, Zepbound from $299, and the Wegovy pen $199 for the first two low-dose fills, then $349. If your commercial plan covers the drug, a savings card can bring it to $25. On Medicare, the GLP-1 Bridge charges $50 a month if you qualify.

July 6, 2026

11 min read

Editorial still-life illustrating an Ozempic versus Wegovy semaglutide comparison
AnalysisComparisons

Ozempic vs Wegovy (2026): Same Drug, $1,028 vs $1,349 List, Here's Which You Need

Verified August 14, 2026: Ozempic and Wegovy are both semaglutide from Novo Nordisk. Ozempic ($1,027.51/mo list) is approved for type 2 diabetes at max 2mg. Wegovy ($1,349/mo list) is approved for weight loss at max 2.4mg (or 7.2mg HD). NovoCare lists each pen at $199/mo for the first two low-dose fills; Wegovy then costs $349/mo at standard strengths ($399 HD), while Ozempic costs $349/mo at 0.25-1mg or $499/mo at 2mg. Pills start at $149/mo and are dose-dependent.

July 2, 2026

18 min read

Editorial still-life illustrating two parallel paths, a calm side-by-side comparison
AnalysisComparisons

Mounjaro vs Ozempic: Weight Loss, Diabetes and Costs

Mounjaro and Ozempic are different diabetes medicines. Tirzepatide produced greater average weight loss in specific trials, but the widely quoted 20.2% versus 13.7% result studied weight-management doses in adults without diabetes. Here is how that changes the comparison.

June 24, 2026

11 min read

Editorial still-life illustrating CagriSema, an investigational injectable weight loss drug from Novo Nordisk
AnalysisNews & Pipeline

CagriSema 2026: Weight Loss Results, FDA Timeline & Why You Can't Buy It Yet

CagriSema (cagrilintide + semaglutide) is not FDA-approved, and you cannot legally buy it yet. In trials it cut average body weight by 22.7% in adults with obesity (REDEFINE 1) and 13.7% in adults with type 2 diabetes (REDEFINE 2) over 68 weeks. Novo Nordisk filed its US application on December 18, 2025, and has not published a decision date.

June 16, 2026

9 min read

Editorial photograph illustrating a comparison of Zepbound and Mounjaro tirzepatide medications
AnalysisComparisons

Zepbound vs Mounjaro: Same Drug, Different Labels, Which Is Right for You?

Zepbound and Mounjaro are the same drug, tirzepatide, at the same doses. Mounjaro is approved for type 2 diabetes and Zepbound for weight management and sleep apnea, so your diagnosis decides which one insurance covers. If you pay cash, Zepbound is cheaper: LillyDirect vials cost $299 to $449 a month, while Mounjaro pens start at $499.

April 22, 2026

12 min read

Editorial photograph illustrating Wegovy oral pill versus injectable comparison
AnalysisComparisons

Wegovy Pill vs Injection: Results, Dosing and Real Costs

The Wegovy pill costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 or 25 mg. The pen costs $199 for the first two low-dose fills, then $349 at standard strengths (prices checked September 20, 2026). You take the pill daily on an empty stomach and the pen once a week, and their results come from separate trials, not a head-to-head test.

April 11, 2026

11 min read

Editorial photograph illustrating compounded tirzepatide and legal considerations
AnalysisCost & Insurance

Is Compounded Tirzepatide Legal and Safe? FDA Rules and What Changed in 2026

It depends on the pharmacy and the prescription. Tirzepatide's shortage ended in October 2024, the broad shortage pathway for compounding closed in early 2025, and FDA has not reviewed compounded tirzepatide for safety or quality. Programs still sell it. Here is what each charges, what the law requires and what to check before you pay.

April 11, 2026

13 min read

Ready to choose a program? Take the 60-second match quiz or see our top-ranked GLP-1 providers.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

from $69/mo·Compounded
Visit EmbodyReview

Collective

from $59/mo + $199/year membership after 21 days·Compounded
Visit CollectiveReview

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

View Gala plansReview

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.